Ref ID: 19422
Author:
J. Van der Werff ten Bosch, R. M. Oostveen, A. de Bel and
M. Van den Akker
Author address:
UZ Brussel, Belgium
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Abstract:
Introduction Between Juli 2010 and December 2012, 8 pediatric
patients with acute lymphoblastic leukemia (ALL) were diagnosed
with invasive aspergillosis during induction therapy. Although the
diagnostic criteria and treatment strategies for invasive aspergillosis
are clear, data lack on how long the treatment should be continued
or how the infection and response to therapy should be monitored. Data 3/8 patients had proven, 4/8 probable and 1/8 possible dis-
ease. All patients were treated with Voriconazole, initially intrave-
nously and afterwards orally. One patient underwent a lobectomy
because a cavernous lesion.
We used imaging studies as the main tool to evaluate the response
till disappearance of the lesions or in case of clinical signs. Vori-
conazol levels were measured weekly.
Findings Voriconazol dosage was aimed to obtain through levels
between 2 an 6 mg/L but most patients had levels below the lower
limit throughout the treatment, notwithstanding adjustment of the
dose. The treatment was continued in all patients until the start of
maintenance therapy. One patient suffered a relapse while treated
with oral Voriconazole.
Conclusion We treated 8 pediatric patients with Voriconazole for
invasive aspergillus. It was difficult to maintain good Voriconazole
trough levels, but nevertheless only one patient suffered a relapse.
No conclusions can be drawn concerning the duration of the treat-
ment, but the fact that 1 patient relapsed indicates that the treat-
ment should be continued at least for several months and careful
monitoring should be continued, even after cessation of therapy.
Abstract Number: p194
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a